Initiation of lipid‐lowering therapy as primary prevention of cardiovascular disease in the elderly
British Journal of Clinical Pharmacology · 2024
DOI: 10.1111/bcp.16157 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von José Manuel Vinuesa-Hernando und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Service, Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Primary Prevention, Hypolipidemic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Instituto de Salud Carlos III, Research Group in Health Services in Aragón (GRISSA), Government of Aragón, Spain.
Abstract (Originalsprache)
Aims
This study aimed to analyse the initiation adherence phase to lipid‐lowering therapy for primary prevention of cardiovascular disease in a Spanish population aged 70 years or older. The secondary objective was to identify the determinants of initiation and early discontinuation.
Methods
This was an observational study conducted in the CArdiovascular Risk factors for HEalth Service research (CARhES) cohort. People aged 70 and older with a first prescription of a lipid‐lowering drug and without a previous major adverse cardiovascular event (MACE) were selected (2018–2021). Data on sociodemographics, clinical conditions, drugs and use of health services were collected from clinical and administrative electronic databases. The study population was classified into: non‐initiation, early discontinuation (i.e., discontinuation after the first dispensing) and initiation with more than one dispensing. Their characteristics were compared. Determinants of initiation and early discontinuation were explored.
Results
Among the 15 019 people studied, 80.2% initiated the medication, 11.2% showed an early discontinuation and 8.6% were non‐initiators. An older age or conditions such as dementia, diabetes or depression reduced the likelihood of initiation, while obesity and a high pharmacological burden increased it. People over 90 years of age or those prescribed a statin in combination were more likely to have an early discontinuation.
Conclusions
Non‐initiation and early discontinuation are common among older people prescribed lipid‐lowering drugs as primary prevention of cardiovascular disease for the first time. The presence of chronic pathologies other than cardiovascular ones should be considered when assessing whether or not to prescribe these drugs in the elderly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacy Service, Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain.
- Department of Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain.
- Grupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.
- Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), ISCIII, Madrid, Spain.
- Pharmacy and Pharmaceutical Technology Department, University of Granada, Granada, Spain.
- Primary Care Pharmacy Service, Sector Zaragoza III, Servicio Aragonés de Salud (SALUD), Zaragoza, Spain.
ORCID-Profile: José Manuel Vinuesa-Hernando, Isabel Aguilar-Palacio, María José Rabanaque, Victoria García-Cárdenas, María Jesús Lallana, Sara Malo
Förderung
- Instituto de Salud Carlos III
- Research Group in Health Services in Aragón (GRISSA), Government of Aragón, Spain
Zitieren
APA
Vinuesa-Hernando, J. M., Aguilar-Palacio, I., Rabanaque, M. J., García-Cárdenas, V., Lallana, M. J., Gamba, A., & Malo, S. (2024). Initiation of lipid‐lowering therapy as primary prevention of cardiovascular disease in the elderly. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16157
Vancouver
Vinuesa-Hernando JM, Aguilar-Palacio I, Rabanaque MJ, García-Cárdenas V, Lallana MJ, Gamba A, et al. Initiation of lipid‐lowering therapy as primary prevention of cardiovascular disease in the elderly. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16157
BibTeX
@article{VinuesaHernando2024,
author = {Vinuesa-Hernando, José Manuel and Aguilar-Palacio, Isabel and Rabanaque, María José and García-Cárdenas, Victoria and Lallana, María Jesús and Gamba, Adriana and Malo, Sara},
title = {Initiation of lipid‐lowering therapy as primary prevention of cardiovascular disease in the elderly},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1111/bcp.16157}
}
EUVIMED